vaccine doses manufactured and distributed across the world in the last one year alone, half of them were manufactured in India, said Union Health Secretary Punya Salila Srivastava. She said this while addressing the annual India Leadership Summit 2024, organised by the US-India Strategic Partnership Forum here today.
Punya said India has emerged as a global leader in pharmaceuticals, being the third-largest producer and a key supplier of generic medicines.
This sector's success has resulted in substantial savings for healthcare systems worldwide, including a notable contribution to the US healthcare system.
«The contribution of the Indian pharmaceutical industry is evidenced by the fact that India has the highest number of US FDA-approved pharmaceutical plants outside of the United States. This is 25 per cent of the total number of US FDA-approved pants outside of the US.
»The medicines from Indian companies, I am told, provided 219 billion USD savings to the US healthcare system in 2022 and a total 1.3 trillion USD savings between 2013 and 2022," she stated.
Office Productivity
Advanced Excel Course — Financial Calculations & Excel Made Easy
By — Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant
Legal
Mastering M&A Deal Making
By — Ashwath Rau, Senior Partner- AZB & Partners
Marketing
Modern Marketing Masterclass by Seth Godin
By — Seth Godin, Former dot com Business Executive and Best Selling Author
Finance
A2Z Of Money
By — elearnmarkets, Financial Education by StockEdge
Office Productivity
Masteri